Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Daria Dubovichenko

1PUBLICATIONS

7CO-AUTHORS

Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Apr 04, 2025

Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma.

Ilya Tsimafeyeu, Alexander Sultanbaev, Daria Dubovichenko

Pageof 1

Frequent Collaborators

1 joint publications

Ilya Tsimafeyeu

1 joint publications

Alexander Sultanbaev

1 joint publications

Makhabbat Murzalina

1 joint publications

Alexander Volkov

1 joint publications

Rashida Orlova

1 joint publications

Igor Utyashev

1 joint publications

Mark Gluzman

Frequent Collaborators

1 joint publications

Ilya Tsimafeyeu

1 joint publications

Alexander Sultanbaev

1 joint publications

Makhabbat Murzalina

1 joint publications

Alexander Volkov

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos